Definium Therapeutics, Inc. (DFTX)
17.55
-0.21
(-1.18%)
USD |
NASDAQ |
Mar 05, 16:00
17.56
+0.01
(+0.06%)
After-Hours: 20:00
Definium Therapeutics Free Cash Flow : -131.84M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pulse Biosciences, Inc. | -54.46M |
| RxSight, Inc. | -19.34M |
| Plus Therapeutics, Inc. | -15.78M |
| Viridian Therapeutics, Inc. | -277.36M |
| Nutriband, Inc. | -5.647M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.89M |
| Cash from Investing (Quarterly) | 37.53M |
| Cash from Financing (Quarterly) | 246.10M |
| Free Cash Flow Per Share (Quarterly) | -0.4241 |
| Free Cash Flow to Equity (Quarterly) | -42.09M |
| Free Cash Flow to Firm (Quarterly) | -40.62M |
| Free Cash Flow Yield | -8.46% |